{
  "metadata": {
    "title": "Age-dependent amyloid deposition is associated with white matter alterations in cognitively normal adults during the adult life span",
    "authors": [
      "Miguel 츼 Araque Caballero",
      "Zhuang Song",
      "Anna Rubinski",
      "Marco Duering",
      "Martin Dichgans",
      "Denise C Park",
      "Dr Michael Ewers"
    ],
    "abstract": "Introduction: Both beta-amyloid (Ab) deposition and decline in white matter integrity, are brain alterations observed in Alzheimers disease (AD) and start to occur by the fourth and fifth decades. However, the association between both brain alterations in asymptomatic subjects is unclear. Methods: Amyloid positron emission tomography (PET) and diffusion tensor imaging (DTI) were obtained in 282 cognitively normal subjects (age 30-89 years). We assessed the interaction of age by abnormal amyloid PET status (Florbetapir F-18 PET 1.2 standard uptake value ratio SUVR) on regional mean diffusivity (MD) and global white matter hyperintensity (WMH) volume, controlled for sex, education, and hypertension. Results: Subjects with abnormal amyloid PET (n  87) showed stronger age-related increase in global WMH and regional MD, particularly within the posterior parietal regions of the white matter. Discussion: Sporadic A洧띻 deposition is associated with white matter alterations in AD predilection areas in an age-dependent manner in cognitively normal individuals.",
    "publication_date": ""
  },
  "content": {
    "INTRODUCTION": {
      "text": "White matter alterations are common in Alzheimers disease (AD). 1 Although cortical neurodegeneration is a core feature of AD, several lines of research suggest that white matter impairment is part of the pathological cascade in AD. 2345 Brain autopsy studies showed partial loss of axons, reduced myelin, and increased astrogliosis in the white matter in patients with pathological diagnosis of AD. 2,6 White matter hyperintensity volume, a gross radiological marker of white matter 5-10 years before symptom onset. 13 Together these results suggest that white matter alterations occur in circumscribed brain regions at an early pre-symptomatic stage of AD. 14 The deposition of cortical amyloid 洧띻 (A洧띻; henceforth we refer only to cortical A洧띻) precedes the onset of Alzheimers disease (AD) symptoms by 20 years, 15,16 typically beginning within the fourth or fifth decade of life. 17,18 A洧띻 deposition has been associated previously with small vessel disease in the form of capillary cortical amyloid angiopathy (CAA) and arteriosclerosis, 6,19,20 which may entail white matter damage. 6,21,22 These observations suggest that the A洧띻 deposition occurring during middle and older age is associated with accelerated age-related white matter alterations, even though the exact mechanisms remain unclear. Results from lifespan diffusion tensor imaging (DTI) studies suggest maturation of fiber tracts to continue until the fourth decade of life, 23 followed by decline in white matter integrity at a higher age. 232425 Few studies, however, have assessed the association between early accrual of A洧띻 deposition and white matter decline in asymptomatic middle-aged and older adults. 4,26272829 In elderly cognitively normal subjects, higher A洧띻 deposition (as assessed by amyloid PET) was associated with DTI alterations within the splenium 30 and cingulum bundle. 31 In late middle-aged cognitively normal subjects, abnormal levels of A洧띻 have only inconsistently been associated with DTI alterations, 12,27,32,33 probably because the small sample size hampered statistical power. 12,32,33 Therefore, the question remains whether microstructural white matter alterations are associated with early cerebral amyloid deposition. In addition, there are few studies of middle-aged adults and it is not clear at what age these associations can be observed. We addressed these questions using a large sample of participants from the Dallas Lifespan Brain Study (DLBS), including 282 cognitively normal adults from age 30-89, allowing us to examine the association between deposition of A洧띻 and white matter alterations across the adult life span. Based on our previous findings of predominantly posterior parietal alterations of MD in autosomal dominant AD 13 , 13 our primary hypothesis was that A洧띻 deposition is associated with a higher age-related increase of MD, particularly in posterior parietal and long-projecting frontoparietal fiber tracts.",
      "subsections": {}
    },
    "Subjects": {
      "text": "We studied 294 cognitively normal subjects from the or DLBS. Inclu-",
      "subsections": {}
    },
    "Cognitive assessments": {
      "text": "The overall cognitive status was assessed with MMSE. Composite scores of episodic memory and executive function were computed as described previously. 34",
      "subsections": {}
    },
    "Assessment of hypertension": {
      "text": "The hypertensive status of the patients in the DLBS has been reported previously. 18 and a 6 mm full width at half maximum (FWHM) Gaussian filter was applied. The computation of global Florbetapir F-18 followed a procedure described previously for Florbetapir F-18 PET scans in the DLBS study. 35 The radiotracer uptake was averaged across voxels within each of eight predefined cortical regions of interest (ROIs), including the dorsolateral prefrontal cortex, orbitofrontal cortex, lateral parietal cortex, posterior and anterior cingulate, precuneus, lateral temporal cortex and occipital cortex. 343536 For each subject and ROI, the average PET values were normalized to the whole cerebellum to compute standard uptake value ratios (SUVR); these PET values were averaged across the eight ROIs to obtain the global SUVR score. 35",
      "subsections": {}
    },
    "Amyloid 洧량 status": {
      "text": "Subjects were classified into two groups based on the global SUVR score, which provided a measure of the magnitude of A洧띻 uptake in the brain. Amyloid positivity (A洧띻) was thresholded at a global SUVR 1.2, as established previously, 35 and participants with a lower global SUVR score were termed amyloid negative (A洧띻-).",
      "subsections": {}
    },
    "DTI pre-processing": {
      "text": "The diffusion-weighted volumes and the b  0 reference volume were pre-processed by a standard procedure implemented in the ExploreDTI toolbox (http:www.ExploreDTI.com). 37 In particular, the DTI scans were corrected for subject motion and eddy currents, and the same transformations that were applied to the diffusion-weighted volumes were also applied to the B-matrix of diffusion directions. 38 For each subject, the thus corrected DTI scan was adjusted subsequently for susceptibility distortions by nonlinear registration to the subjects brain-extracted T1 volume, using the Explore DTI toolbox. 39 A particular feature of this procedure is that the deformations can be restricted to the phase-encoding direction of the DTI scan (ie, the anterior-posterior direction in our case). Finally, diffusion-tensor estimation by ordinary least-squares was carried out to generate fractional anisotropy (FA as required for tract-based spatial statistics TBSS, see next section) and MD maps for each subject.",
      "subsections": {}
    },
    "Tract-based spatial statistics": {
      "text": "The MD maps were superimposed onto a white matter skeleton template, using TBSS 40 included in the FSL toolbox (https:fsl.fmrib.\nox.ac.ukfslfslwiki). The skeletonized MD maps were normalized to the FMRIB58 FA template in MNI space, using the spatial normalization routine and standard parameters of TBSS. 40 Then the obtained MD maps were multiplied with a conservatively defined binary white matter skeleton mask adopted from the TBSS toolbox to reduce partial volume effects, excluding the fornix and other regions susceptible to such effects, as described previously. 41 For the extraction of fiber tract ROI values of MD, the binarized Johns-Hopkins University fiber tract atlas 42 in MNI space was superimposed onto each subjects skeletonized MD map and the mean MD was computed for each fiber tract ROI.",
      "subsections": {}
    },
    "White matter hyperintensity measurement and probability mapping": {
      "text": "White matter hyperintensities (as defined by the standards for reporting vascular changes on neuroimaging (STRIVE) criteria) 43 were segmented based on FLAIR MRI scans, using a semiautomated method that was described previously. 44 (For a more detailed description see Statistical significance was determined based on the Randomise Toolbox of FSL, 45 conducting nonparametric permutation inference using threshold-free cluster enhancement (TFCE; recommended for TBSS analyses) to correct for family-wise error (FWE).\nIn order to assess whether some patients had abnormal cognitive performance, we expressed each patients composite score of episodic memory and executive function in terms of SD) from the group mean.\nComposite scores were adjusted by age, gender, and years of education as described in, 3 We considered subjects with z adj  -1.5 (ie, 1.5 SDs below the adjusted mean) in either episodic memory or executive function as potentially not cognitively healthy.\nResults showed that in total, 4 of 282 (1 A洧띻-and 1 A洧띻) were below the episodic memory threshold only.",
      "subsections": {}
    },
    "ROI-based analysis of the effect of age and A洧량 on MD": {
      "text": "When analyzed at the fiber-tract ROI level, A洧띻 status was associated numerically with higher age-related increase in MD within multiple tracts that were largely consistent with the location of significant voxel clusters of the interaction effect reported in the TBSS analysis (Supplementary Figure S2, Supplementary Table S2). However, the test of the interaction effects were not statistically significant after Bonferroni correction. This was probably because MD alterations were observed only in parts of a tract, so that averaging the MD values across all voxels of a tract diluted the effect and thus reduced statistical power.\nLinear regression analysis of the interaction effect of APOE genotype x age did not yield significant results for any of the fiber tracts (data not shown). S3). In both groups, WMH occurred predominantly in the periventricular white matter. Regression analysis showed a significant interaction A洧띻 status x age on the global WMH ratio (B  0.30, standard error SE  0.14, 95",
      "subsections": {}
    },
    "Assessing the influence of the APOE genotype": {
      "text": "We tested whether the APOE 洧4 genotype (洧4 carrier vs no 洧4 carrier) was associated with the main predictors, that is, age (through a t test)\nand A洧띻 PET status (via chi-square).\nIn a TBSS analysis, APOE genotype and interaction term APOE genotype x age were tested as predictors of MD, controlled for age, gender, and education, using non-parametric permutation inference using threshold-free cluster enhancement (TFCE; recommended for TBSS analyses) to correct for family-wise error (FWE), with a corrected significance threshold of 洧띺  0.05.",
      "subsections": {}
    },
    "Analysis of the effect of age and A洧량 on WMH": {
      "text": "F I G U R E 1 TBSS map of the interaction effect of age x global A洧띻 PET status (A洧띻-vs A洧띻) on MD within the white matter (WM) skeleton (blue) in the axial view (upper two rows) and sagittal view (lower two rows). At higher levels of global amyloid PET, age was associated with a stronger increase in MD than at lower levels of global amyloid PET. No interaction effects were observed in the opposite direction. P-values associated with the interaction effect are encoded in warm colors (red to yellow); the significance level was P  0.05 FWE corrected TA B L E 2 Voxel-based analysis: anatomical labels, coordinates in MNI space, and t value of the TBSS-derived peaks of each cluster of the interaction effects of A洧띻 PET status by age on MD Abbreviations: L, left, R, right.\nconfidence interval CI  0.07-0.59, P  0.026), such that the association between higher age and higher global WMH ratio was stronger in the A洧띻 compared to the A洧띻-group (Figure 3). To ensure that zero or very low values of WMH volume did not influence the results, we repeated the regression analysis with cases of WMH volume below the fifth percentile (n  25) excluded (B  0.29, SE  0.14, 95 CI  0.02-0.58, P  0.037). The interaction effect remained also significant when controlling for hypertension (full sample: B  0.33, SE  0.13, 95 CI  0.07-0.59, P  0.015), where hypertension had no significant effect on WMH ratio (data not shown).",
      "subsections": {}
    },
    "Patients characteristics": {
      "text": "Patients characteristics are displayed in Table 1 for the A洧띻 groups.\nA洧띻 patients were older (t  6.4, P  0.001) and had lower executive",
      "subsections": {}
    },
    "TBSS analysis of the effect of age and A洧량 status on MD": {
      "text": "TBSS analysis showed a significant A洧띻 status x age interaction for MD.\nIn A洧띻 patients, higher age was associated with a stronger increase in MD compared to that in A洧띻-patients. The peak interaction effects of A洧띻 status x age were located predominantly within the posterior parietal white matter including fiber tracts such as the forceps major and long-projecting fibers connecting posterior brain regions (Figure 1, Table 2). The results remained virtually unchanged when excluding those four patients who scored 1.5 SD below the mean on the composite scores of episodic memory or executive function, suggesting that the findings were not driven by abnormally low-performing subjects. When using global A洧띻 PET SUVR as a continuous rather than binary measure, the interaction effect global A洧띻 PET SUVR x age on MD remained significant in the same tracts (except for the anterior thalamic radiation, Supplementary Figure S1 and Supplementary Table S1), albeit in a more spatially restricted manner.\nTBSS analysis of the effect of APOE genotype x age interaction on MD values did not yield any significant results (data not shown).",
      "subsections": {}
    },
    "DISCUSSION": {
      "text": "The major results of the current adult life span study in cognitively normal subjects (30-89 years) showed abnormal global A洧띻 deposi-tion (global Florbetapir F-18 PET) to be associated with stronger age-related MD alterations, particularly within the posterior parietal white matter. A洧띻 status was also associated with stronger agerelated increase in global WMH volume, independent of hypertension.\nTogether, these results suggest that A洧띻 deposition is associated with white matter alterations throughout the adult life span in cognitively normal subjects.\nIncreased MD in the posterior parietal white matter included fiber tracts such as the forceps major, inferior frontooccipital fasciculus, and superior longitudinal fasciculus. These fiber tracts connect among others regions of the default mode network (DMN), 47 that is, a major functional network impaired in both cognitively normal subjects with elevated A洧띻 levels 48,49 and patients with AD dementia. 50 White matter alterations in tracts connecting the DMN were shown previously to be associated with reduced functional connectivity in patients with AD, 44 suggesting that white matter The posterior parietal spatial distribution of MD alterations observed in the current study shows a spatial similarity to that previously found in mild AD 51,52 (for review see 53 ), and in subjects with autosomal dominant AD. 13 In autosomal dominant AD, we previously reported higher MD within the forceps major 10 years before symptom onset, with other major long-projecting fibers tracts such as the inferior frontooccipital fasciculus, superior longitudinal fasciculus, and forceps minor affected subsequently. 13 Similarly, in the current study, we observed significant amyloid-related MD increase that was located primarily in temporal and posterior brain regions. It should be noted that the white matter alterations extended to frontal fiber tracts such as the anterior thalamic radiation. Alterations in the frontal white mat-ter, including among other regions the anterior thalamic radiation, have been reported previously in late-onset AD. 54,55 It is thus possible that due to the age difference between autosomal dominant Alzheimers disesae compared to late onset AD, 13 more frontal white matter alterations are present in late-onset AD. Whether regional differences in A洧띻 PET contribute to regionally matching differences in MD alterations was not possible to address in the current study, given that local A洧띻 PET values are highly intercorrelated and thus regional A洧띻 PET changes are difficult to disentangle from global A洧띻 PET changes.\nThe underlying mechanisms of A洧띻-related MD alterations remain unclear. One possibility is that the deposition of A洧띻 enhances small vessel disease, in the form of cerebral amyloid angiopathy (CAA).\nWhite matter damage in AD might thus be related to vascular mechanisms, such as hypoperfusion (for reviews see 6,56 ). Cerebrovascular and its prevalence is also increased in cognitively normal subjects exhibiting neuritic amyloid plaques. 58 A洧띻 induces vasoconstriction and reduces functional hyperemia, as observed in mouse models of cerebral A洧띻 deposition. 56,59 Furthermore, higher parenchymal A洧띻 may enhance CAA and associated perfusion alterations. 60 Microstructural white matter alterations becoming visible as WMH have been associated\npreviously with small vessel disease changes including capillary CAA and hypoperfusion. 21,61 In the current study, we found higher agerelated increase in WMH volume in subjects with abnormal Florbetapir F-18 PET levels compared to those with normal Florbetapir F-18\nPET. Consistent with our results, relatively young patients with autosomal dominant AD showed an increase in WMH subsequent to amyloid deposition, 7 suggesting that amyloid pathology may entail white matter alterations. In humans, arterial spin labeling studies showed that lower tissue perfusion was associated not only with WMH volume but also DTI alterations in fiber tracts outside the WMH. 62 Together, these results suggest that A洧띻-related small vessel disease constitutes a potential pathomechanism underlying the microstructural fiber tract alterations observed in the current study.\nHypertension is an age-related cerebrovascular risk factor and may thus enhance the risk of white matter alterations. In addition, cerebrovascular disease has been suggested to enhance the development of AD, 63 and thus hypertension may not only be a vascular risk factor but also a risk factor for enhanced accumulation of A洧띻 in the brain. 18 In our study, the effects of A洧띻 on both MD alterations and WMH were, however, independent of the hypertension status, suggesting that hypertensive small vessel disease does not account for the observed effects on white matter. It is still possible that hypertension enhances the development of A洧띻 18 and exacerbates A洧띻-related small vessel disease, 64 but in the current study, hypertension was not the major determinant. We caution, however, that in the majority of cases hypertension was treated, and thus any effects of hypertension may have been attenuated by treatment. Multiple sources may synergisti-cally contribute to white matter alterations and cognitive decline, 656667 where future studies need to address the causative relationship and mechanistic pathways between these factors.\nFor the interpretation of the current study, some caveats should be considered. Although an increase in MD is commonly thought to reflect decreased fiber tract integrity, the exact sources of changes in DTI signal are not well understood. 68,69 Changes in MD may be influenced by changes in crossing fibers 10,68,69 or an increase in extracellular free water without pronounced alterations of fiber tract structure itself, 70 which complicates the attribution of MD differences to underlying changes in fiber tract integrity. Multishell acquisition protocols and free water elimination have been developed 717273 to alleviate such shortcomings; however, this work is ongoing. 74 Furthermore, we focused on MD only, and our results do not necessarily generalize to other DTI indices such as fractional anisotropy (FA), even though we found that MD and FA were highly correlated in our data set (data not shown). Another caveat is that the current study does not include longitudinal data, which would be instructive to establish the temporal sequence of age-related development of A洧띻 and white matter changes during the adult life span. 63,75 Reduced perfusion and impaired bloodbrain barrier function have been proposed to precede the development of A洧띻. 1,56,57 Furthermore, small vessel disease may interact with A洧띻 pathology, and thus exacerbate the development of AD pathology. 64,76 The current cross-sectional findings cannot disentangle the directionality of the effect that white matter alterations, possibly stemming from small vessel disease, and A洧띻 pathology may exert on each other.\nLastly, we note that while our results suggest A洧띻 to be associated with white matter alterations at higher age, one alternative possibility is that the association between A洧띻 and white matter alterations becomes better detectable at higher age, where white matter integrity is more variable. Biological factors that may enhance the association between A洧띻 and white matter alterations specifically at higher age remain still unclear. In conclusion, the current study shows that the occurrence of A洧띻 deposition is associated with an age-related increase in white matter alterations. Our results have clinical implications. Small vessel disease is treatable, and interventions enhancing vascular health at an early disease stage may thus alleviate disease progression in patients with increased levels of A洧띻. 77 Recently developed, clinically applicable neuroimaging markers of white matter damage 41 could help track white matter alterations and treatment effects, both in response to vascular or A洧띻-targeted intervention for secondary prevention.",
      "subsections": {}
    },
    "FUNDINGSUPPORT": {
      "text": "The study was supported by the Alzheimers Association (to M.E.), European Research Council PCIG12-GA-2012-334259 (to M.E),\nLMUexcellent (to M.E.), National Institute on Aging 5R37AG-006265 (to D.P.) and RC1AG036199 (to D.P.). The PETtracer was provided at no cost by Avid Radiopharmaceuticals, a wholly owned subsidiary of Eli Lilly, Inc, which had no role in the design and conduct of the study, analysis of the data, or manuscript preparation.",
      "subsections": {}
    }
  }
}